Flerie AB (publ)

kr 12.80As of Sun 8 Nov 2026, 12:00 UTC
STO:FLERIEHealthcare
Country Sweden
PE (Fwd) •••
TSR 2Y CAGR (39.16%)
Div yield —
ROE (27.74%)
Biotechnology
Beta (5Y) (0.29)
PE TTM —
TSR TTM (63.70%)
Mkt cap kr 1.110B
ROIC (0.59%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 13
4.18%
(81.75%)
Hold 3|1|1|6|5
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.23
0.24
0.25
0.24
18.16%
12.22%
14.52%
11.71%
Revenuekr M
57.47
58.56
60.19
60.19
13.42%
9.42%
7.84%
7.53%
Peers (US$112.2M)
Cap (US$)
PE
143.9M
68.15x
86.51M
—
Capital
TTM
5Y
10Y
Leveragex
0.689
(0.015)
(0.014)
EBIT/Intx
4.188
0.222
0.247
Own earn%
(116.18)
201.74
169.05
Sh yield%
37.25
35.01
33.27
Owners
Insiders/Inst%
11.81
22.66
Short interest%
3.35
SBC / revenue%
5.87
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
10–16
$1 testx
0.0
Incr. ROIC%
9